F. Žák

683 total citations
32 papers, 531 citations indexed

About

F. Žák is a scholar working on Oncology, Infectious Diseases and Materials Chemistry. According to data from OpenAlex, F. Žák has authored 32 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Infectious Diseases and 4 papers in Materials Chemistry. Recurrent topics in F. Žák's work include Metal complexes synthesis and properties (7 papers), Lanthanide and Transition Metal Complexes (4 papers) and Parasitic Diseases Research and Treatment (3 papers). F. Žák is often cited by papers focused on Metal complexes synthesis and properties (7 papers), Lanthanide and Transition Metal Complexes (4 papers) and Parasitic Diseases Research and Treatment (3 papers). F. Žák collaborates with scholars based in Czechia, Switzerland and Croatia. F. Žák's co-authors include Petr Sova, Donna J. McComb, K Kovács, Alois Kozubı́k, Jaroslav Tuřánek, Lenka Šindlerová, P. Málek, J Kolc, P Poučková and M Zadinová and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Journal of Medicinal Chemistry and The Journal of Urology.

In The Last Decade

F. Žák

29 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Žák Czechia 14 202 142 84 54 43 32 531
Jun Chiba Japan 16 92 0.5× 213 1.5× 213 2.5× 78 1.4× 10 0.2× 62 706
Giovanni Francesco Fasciglione Italy 17 198 1.0× 293 2.1× 38 0.5× 34 0.6× 9 0.2× 28 842
Jutta Schlepper‐Schäfer Germany 18 113 0.6× 432 3.0× 59 0.7× 10 0.2× 26 0.6× 26 873
D Sabolović France 13 61 0.3× 185 1.3× 23 0.3× 43 0.8× 17 0.4× 52 717
William F. McLimans United States 14 89 0.4× 378 2.7× 40 0.5× 11 0.2× 20 0.5× 28 748
Osamu Yoshida Japan 11 93 0.5× 192 1.4× 78 0.9× 10 0.2× 26 0.6× 33 566
Sarah Di Somma Italy 15 220 1.1× 263 1.9× 29 0.3× 22 0.4× 47 1.1× 23 641
Michael Stanton United Kingdom 12 198 1.0× 298 2.1× 12 0.1× 115 2.1× 26 0.6× 21 856
Hao Cai China 16 164 0.8× 313 2.2× 29 0.3× 86 1.6× 45 1.0× 34 761
John G. Kidd United States 12 80 0.4× 287 2.0× 29 0.3× 16 0.3× 17 0.4× 17 745

Countries citing papers authored by F. Žák

Since Specialization
Citations

This map shows the geographic impact of F. Žák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Žák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Žák more than expected).

Fields of papers citing papers by F. Žák

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Žák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Žák. The network helps show where F. Žák may publish in the future.

Co-authorship network of co-authors of F. Žák

This figure shows the co-authorship network connecting the top 25 collaborators of F. Žák. A scholar is included among the top collaborators of F. Žák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Žák. F. Žák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hrstka, Roman, Darren Powell, Eva Roubalová, et al.. (2008). The novel platinum(IV) complex LA-12 induces p53 and p53/47 responses that differ from the related drug, cisplatin. Anti-Cancer Drugs. 19(4). 369–379. 21 indexed citations
2.
Procházka, Lubomír, Jaroslav Tuřánek, Radek Tesařı́k, et al.. (2007). Apoptosis and inhibition of gap-junctional intercellular communication induced by LA-12, a novel hydrophobic platinum(IV) complex. Archives of Biochemistry and Biophysics. 462(1). 54–61. 18 indexed citations
3.
Sova, Petr, et al.. (2006). Comparative anti-tumor efficacy of two orally administered platinum(IV) drugs in nude mice bearing human tumor xenografts. Anti-Cancer Drugs. 17(2). 201–206. 25 indexed citations
4.
Sova, Petr, et al.. (2005). Preclinical anti-tumor activity of a new oral platinum(IV) drug LA-12. Anti-Cancer Drugs. 16(6). 653–657. 29 indexed citations
5.
Kozubı́k, Alois, Viktor Horváth, Lenka Šindlerová, et al.. (2004). High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro. Biochemical Pharmacology. 69(3). 373–383. 50 indexed citations
6.
7.
8.
Žák, F., Jaroslav Tuřánek, Petr Sova, et al.. (2003). Platinum(IV) Complex with Adamantylamine as Nonleaving Amine Group:  Synthesis, Characterization, and in Vitro Antitumor Activity against a Panel of Cisplatin-Resistant Cancer Cell Lines. Journal of Medicinal Chemistry. 47(3). 761–763. 66 indexed citations
9.
Zea-Flores, G, et al.. (1991). Amocarzine investigated as oral onchocercacidal drug in 272 adult male patients from Guatemala. Results from three dose regimens spread over three days.. PubMed. 42(3). 240–62. 8 indexed citations
10.
Žák, F., et al.. (1985). Evaluation of skin carcinogenicity of technical 2,2-bis-(p-glycidyloxyphenyl)-propane in CF1 mice. Food and Chemical Toxicology. 23(12). 1081–1089. 4 indexed citations
11.
Herzog, U, Philippe Marty, & F. Žák. (1985). Pentastomiasis : case report of an acute abdominal emergency. PubMed. 42(3). 261–71. 23 indexed citations
12.
Thomann, P., et al.. (1974). The assessment of peripheral neurotoxicity in dogs: comparative studies with acrylamide and clioquinol. Inflammation Research. 4(1). 47–53. 12 indexed citations
13.
Pokorný, J, et al.. (1968). Experimental immunity against tuberculosis evoked by peptidoglycolipids of the wax D type.. PubMed. 136(2). 118–28.
14.
Žák, F.. (1964). Contribution to the Origin, Development and Experimental Production of Laminated Calcinosiderotic Schaumann Bodies. Acta Medica Scandinavica. 176(S425). 21–24. 4 indexed citations
15.
Žák, F., et al.. (1964). Co-existent pheochromocytoma and thyroid carcinoma. 31(6). 476–486. 1 indexed citations
16.
Málek, P., et al.. (1963). Fluorescence of Tetracycline Analogues Fixed in Myocardial Infarction. Cardiology. 42(5). 303–318. 28 indexed citations
17.
18.
Málek, P., J Kolc, & F. Žák. (1959). Zur Frage der Beschädigung der Lymphknoten durch Kontrastmittel bei der Lymphographie. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 91(7). 46–59. 1 indexed citations
19.
Málek, P., J Kolc, & F. Žák. (1959). [Lymphography in experimental anthrax infection].. PubMed. 174(1-2). 94–109. 1 indexed citations
20.
Žák, F., et al.. (1958). SOLITARY BRONCHIAL POLYPS OF INFLAMMATORY ORIGIN. Journal of Thoracic Surgery. 35(6). 807–815. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Chiba Breakdown of academic impact, for papers by Giovanni Francesco Fasciglione Breakdown of academic impact, for papers by Jutta Schlepper‐Schäfer Breakdown of academic impact, for papers by D Sabolović Breakdown of academic impact, for papers by William F. McLimans Breakdown of academic impact, for papers by Osamu Yoshida Breakdown of academic impact, for papers by Sarah Di Somma Breakdown of academic impact, for papers by Michael Stanton Breakdown of academic impact, for papers by Hao Cai Breakdown of academic impact, for papers by John G. Kidd
Rankless by CCL
2026